In-depth characterization of protein N-glycosylation for a COVID-19 variant-design vaccine spike protein

• Published in: Analytical and bioanalytical chemistry Vol. 415; no. 8; pp. 1455 - 1464
• Main Authors: Huang, Jiangming, Hou, Shouzeng, An, Jiao, Zhou, Chenliang
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.03.2023; Springer; Springer Nature B.V
• Subjects: Analytical Chemistry; Animals; Antigens; Biochemistry; Characterization and Evaluation of Materials; Chemistry; Chemistry and Materials Science; CHO Cells; Chromatography, Liquid; Coronaviruses; COVID-19; COVID-19 - prevention & control; COVID-19 Vaccines; Cricetinae; Cricetulus; Design; Food Science; Glycan; Glycopeptides; Glycosylation; Health aspects; Humans; Immunogenicity; Laboratory Medicine; Monitoring/Environmental Analysis; Mutation; N-glycans; Pandemics; Physiological aspects; Polysaccharides; Polysaccharides - chemistry; Proteins; Quality control; Research Paper; SARS-CoV-2 - genetics; Sequence analysis; Severe acute respiratory syndrome coronavirus 2; Spike Glycoprotein, Coronavirus - chemistry; Spike protein; Tandem Mass Spectrometry; Trypsin; Vaccines; Viral diseases; Viral proteins; Viruses; China; Variant; COVID-19 spike protein; Glycosylation; Mass spectrometry
• ISSN: 1618-2642; 1618-2650
• DOI: 10.1007/s00216-023-04533-w

COVID-19 is caused by SARS-CoV-2 infection and remains one of the biggest pandemics around the world since 2019. Vaccination has proved to be an effective way of preventing SARS-CoV-2 infection and alleviating the hospitalization burden. Among different forms of COVID-19 vaccine design, the spike protein of SARS-CoV-2 virus is widely used as a candidate vaccine antigen. As a surface protein on the virus envelop, the spike was reported to be heavily N-glycosylated and glycosylation had a great impact on its immunogenicity and efficacy. Besides, N-glycosylation might vary greatly on different expression systems and sequence variant designs. Therefore, comprehensive analysis of spike N-glycosylation is of great significance for better vaccine understanding and quality control. In this study, full characterization of N-glycosylation was performed for a Chinese Hamster Ovary (CHO) cell expressed variant-designed spike protein. The spike protein featured the latest six-proline substitution design together with the incorporation of a combination of mutation sites. Trypsin and Glu-C digestion coupled with PNGase F strategies were adopted, and effective LC–MS/MS methods were applied to analyze samples. As a result, a total of 19 N-glycosites were identified in the recombinant pike protein at intact N-glycopeptide level. Quantitative analysis of released glycan by LC–MS/MS was also performed, and 31 high-abundance N-glycans were identified. Sequencing analysis of glycan was further provided to assist glycan structure confirmation. Moreover, all of the analyses were performed on three consecutive manufactured batches and the glycosylation results on both glycosite and glycans showed good batch-to-batch consistency. Thus, the reported analytical strategy and N-glycosylation information may well facilitate studies on SARS-CoV-2 spike protein analysis and quality studies. Graphical Abstract